GW Pharmaceuticals Plc
(NASDAQ : GWPH)

( )
GWPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
-5.91%22.601.7%$275.39m
VRXValeant Pharmaceuticals International, Inc.
-0.26%28.4114.1%$167.17m
BHCBausch Health Cos., Inc.
-0.26%28.410.0%$117.01m
MDCOThe Medicines Co.
12.83%58.6520.2%$98.11m
GWPHGW Pharmaceuticals Plc
-5.48%102.476.2%$82.22m
JAZZJazz Pharmaceuticals Plc
-0.01%138.622.3%$65.32m
PRGOPerrigo Co. Plc
-0.83%48.976.8%$52.67m
SAGESAGE Therapeutics, Inc.
-0.25%145.968.6%$52.20m
UTHRUnited Therapeutics Corp.
0.25%90.6614.3%$40.59m
ICPTIntercept Pharmaceuticals, Inc.
0.92%83.0116.9%$39.46m
HZNPHorizon Therapeutics Plc
1.54%30.736.6%$39.14m
ICLRICON plc
-0.38%154.014.2%$38.41m
ENDPEndo International Plc
-1.66%4.468.8%$37.22m
CTLTCatalent, Inc.
0.02%50.432.4%$31.84m
ARGXargenx SE
1.52%141.490.0%$27.38m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.